Can You Take Weight Loss Injections With Antidepressants?

What official guidance actually says about GLP-1 medicines and other oral drugs

The published Summaries of Product Characteristics for both tirzepatide (Mounjaro) and semaglutide (Wegovy) flag slowed gastric emptying as a relevant pharmacological property. This is partly how both medicines reduce appetite, but it does mean that oral medicines taken at the same time pass through the stomach more slowly than usual. The NHS guidance on weight management injections notes this as something to discuss with your prescriber or pharmacist, particularly for medicines where consistent absorption timing matters.

For most antidepressants, this is unlikely to cause a clinically meaningful problem. SSRIs and SNRIs, for example, are not highly sensitive to small shifts in absorption rate, and they have wide therapeutic windows. However, the effect is not zero, and your prescriber needs to know every medicine you take. The BNF entry for tirzepatide cross-references interactions with oral drugs broadly, which is why a thorough medicines review at the point of consultation is part of the process, not an optional extra.

A question our prescribers hear most weeks is whether a long-standing antidepressant prescription means treatment simply cannot go ahead. In the vast majority of cases, the answer is that it can, but the full picture matters. Dose, the specific agent, how stable your mental health currently is, and your reason for managing weight all feed into that assessment.

What the evidence shows about mood and weight loss medicines

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled thousands of adults across a broad range of health profiles; participants on stable background medications were included. Serious psychiatric adverse events were not identified as a signal in the trial data for tirzepatide. The STEP 1 trial for semaglutide 2.4mg, also published in the New England Journal of Medicine, similarly did not identify depression or mood worsening as a notable finding.

There is emerging research interest in whether GLP-1 receptor agonists might have direct effects on mood, reward pathways and anxiety, and if you want to understand what the current evidence does and does not show, our page on whether weight loss injections can cause depression covers that question in detail. What is well-established is that the medicines reduce appetite and alter how satisfying food feels, and for some people this has an emotional dimension that sits alongside any existing mental health condition. Our page on weight loss injections and depression covers this in more depth.

Because these are relatively new medicines in the weight management setting, the MHRA continues to collect post-market data through its Yellow Card scheme. Suspected side effects, including any changes in mood, can and should be reported at yellowcard.mhra.gov.uk. This is how the safety picture is refined over time.

Who may need extra caution, and when to involve your GP or psychiatrist

There are some situations where the combination of a weight loss injection and an antidepressant calls for more than a standard prescriber review. If your mental health diagnosis is recent or unstable, if your antidepressant dose has changed in the past few months, or if you have a current or recent history of an eating disorder, these are circumstances where your GP or psychiatrist should be part of the conversation before starting treatment. The NHS overview of weight management injections is clear that existing mental health conditions are part of the clinical picture a prescriber assesses, not a detail to mention after a prescription is written.

Some people ask whether certain antidepressants that are associated with weight gain might interact with a weight loss medicine in a way that reduces its effectiveness. Weight gain as a side effect of an antidepressant is real and well-documented for some agents, and it does not necessarily mean a GLP-1 medicine will not work, but it is a relevant piece of clinical context your prescriber should have.

It is also worth knowing that if you are considering a weight loss injection and your antidepressant is taken once daily in the morning, the timing of your tablet dose relative to food and other medicines is something to confirm with whoever reviews your prescription. This is particularly relevant to people managing multiple conditions with oral medications at once. None of this is a reason not to ask the question. It is exactly the kind of clinical nuance that a proper consultation is designed to work through.

Starting the conversation: how to get a proper assessment

The right starting point is a clinical consultation where your antidepressant, your mental health history and your weight-related health are all on the table at once. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber the same day — a real clinician reads your answers, not a scoring algorithm. If anything in your history needs clarification, including your current medication list, our prescribers will ask. You can learn more about the clinical team involved in that process on our clinical lead's profile page.

If you are not sure whether you might be eligible, our general guide to who can take weight loss injections sets out the licensed criteria in plain terms. The short version: adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition, may be considered, subject to the full clinical assessment. A prescriber always makes the final call.

Cost is sometimes a factor when people are weighing up whether to pursue private treatment. Our overview of how much weight loss injections cost explains what a legitimate private price typically includes, and why clinical oversight is part of what that price covers. One transparent fee at nume covers consultation, prescription, medicine and free next-working-day delivery. No subscription and no hidden charges. Speak to our prescribers to see whether treatment is right for you.